Description

The concentration of the mitochondrial protein frataxin can be used to both diagnose and monitor treatment for patients with Friedreich ataxia (FA). Decreased frataxin protein levels are diagnostic of FA and can be utilized for monitoring known patients. FA is an autosomal recessive disease affecting approximately 1:50,000 Caucasians. The disease is clinically characterized by progressive spasticity, ataxia, dysarthria, absent lower limb reflexes, sensory loss, and scoliosis. Hypertrophic cardiomyopathy is present in approximately two-thirds of patients with FA and the most frequent cause of premature death. FA is caused by mutations in the FXN gene encoding frataxin. Source: Regenstrief LOINC

Basic Part Properties

Part Name
Frataxin
Part Display Name
Frataxin
Part Type
Component (Describes the core component or analyte measured)
Created On
2016-02-25
Construct for LOINC Short Name
Frataxin

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP207802-2

Language Variants Get Info

TagLanguageTranslation
zh-CNChinese (China)线粒体型共济失调蛋白
Synonyms: 铁硫簇相关蛋白;Frataxin 蛋白;FXN;线粒体型共济失调蛋白 X25;Frataxin
es-ESSpanish (Spain)Frataxina
it-ITItalian (Italy)Fratassina
nl-NLDutch (Netherlands)frataxine
fr-FRFrench (France)Frataxine
el-GRGreek (Greece)Φραταξίνη
Synonyms: Φραταξίνη